Dianthus Therapeutics (DNTH) Cash & Equivalents Growth (1y) (2018 - 2025)
Dianthus Therapeutics (DNTH) Cash & Equivalents Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | 128.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 128.96% |
| Sep 30, 2025 | 63.33% |
| Jun 30, 2025 | -95.79% |
| Mar 31, 2025 | -96.93% |
| Dec 31, 2024 | -83.42% |
| Sep 30, 2024 | -78.59% |
| Jun 30, 2024 | 679.96% |
| Mar 31, 2024 | 1,320.49% |
| Dec 31, 2023 | 761.21% |
| Sep 30, 2023 | 326.46% |
| Jun 30, 2023 | -26.54% |
| Mar 31, 2023 | -67.66% |
| Dec 31, 2022 | -88.33% |
| Sep 30, 2022 | -76.59% |
| Jun 30, 2022 | -64.63% |
| Mar 31, 2022 | 45.60% |
| Dec 31, 2021 | 126.39% |
| Sep 30, 2021 | 11.19% |
| Jun 30, 2021 | 13.76% |
| Mar 31, 2021 | -34.22% |